(ZS) Zscaler - Ratings and Ratios
Cloud, Threat, Data, Branch, Operations
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 40.5% |
| Value at Risk 5%th | 63.5% |
| Relative Tail Risk | -4.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 3.26 |
| CAGR/Max DD | 0.70 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.411 |
| Beta | 1.247 |
| Beta Downside | 1.250 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.06% |
| Mean DD | 15.25% |
| Median DD | 14.44% |
Description: ZS Zscaler December 03, 2025
Zscaler, Inc. (NASDAQ:ZS) is a pure-play cloud security vendor that delivers a portfolio of Zero Trust solutions-including Zscaler Internet Access, Zscaler Private Access, Zero Trust Firewall, and a suite of data-security, threat-intelligence, and digital-experience tools-designed to protect users, applications, and data across any network or device.
The company’s offerings span the full Zero Trust stack: secure web gateway, secure access service edge (SASE), cloud sandboxing, data loss prevention, SaaS security, and managed detection & response, and are sold to a broad set of verticals such as financial services, healthcare, manufacturing, technology, and the public sector.
Key recent performance metrics: FY 2024 revenue reached approximately $2.1 billion, up ~13% YoY; annual recurring revenue (ARR) topped $3.5 billion with a net dollar retention rate of roughly 130%; and gross margins remained near 78%, reflecting the high-margin nature of subscription-based cloud software.
Sector-level drivers reinforce Zscaler’s growth outlook: worldwide cybersecurity spend is projected by Gartner to exceed $226 billion by 2025, with cloud-native security solutions growing faster than any other segment; additionally, regulatory mandates (e.g., CMMC, GDPR) and the continued shift to remote/hybrid work are accelerating enterprise adoption of Zero Trust architectures.
For a deeper, data-driven view of Zscaler’s valuation dynamics, you may find ValueRay’s analyst framework worth exploring.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-41.0m TTM) > 0 and > 6% of Revenue (6% = 170.0m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -0.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 67.07% (prev 18.71%; Δ 48.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 1.09b > Net Income -41.0m (YES >=105%, WARN >=100%) |
| Net Debt (495.8m) to EBITDA (123.2m) ratio: 4.02 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (158.6m) change vs 12m ago 3.96% (target <= -2.0% for YES) |
| Gross Margin 76.66% (prev 77.81%; Δ -1.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 50.54% (prev 48.82%; Δ 1.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.38 (EBITDA TTM 123.2m / Interest Expense TTM 8.45m) >= 6 (WARN >= 3) |
Altman Z'' 1.04
| (A) 0.29 = (Total Current Assets 4.21b - Total Current Liabilities 2.31b) / Total Assets 6.50b |
| (B) -0.18 = Retained Earnings (Balance) -1.20b / Total Assets 6.50b |
| (C) 0.00 = EBIT TTM 3.22m / Avg Total Assets 5.61b |
| (D) -0.26 = Book Value of Equity -1.19b / Total Liabilities 4.52b |
| Total Rating: 1.04 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.88
| 1. Piotroski 2.50pt |
| 2. FCF Yield 2.38% |
| 3. FCF Margin 29.93% |
| 4. Debt/Equity 0.93 |
| 5. Debt/Ebitda 4.02 |
| 6. ROIC - WACC (= -9.98)% |
| 7. RoE -2.28% |
| 8. Rev. Trend 98.58% |
| 9. EPS Trend 31.44% |
What is the price of ZS shares?
Over the past week, the price has changed by -0.66%, over one month by -8.34%, over three months by -22.36% and over the past year by +25.88%.
Is ZS a buy, sell or hold?
- Strong Buy: 24
- Buy: 9
- Hold: 11
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the ZS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 326.8 | 41.8% |
| Analysts Target Price | 326.8 | 41.8% |
| ValueRay Target Price | 246.2 | 6.8% |
ZS Fundamental Data Overview December 22, 2025
P/E Forward = 60.9756
P/S = 13.0891
P/B = 18.7078
P/EG = 3.0558
Beta = 1.066
Revenue TTM = 2.83b USD
EBIT TTM = 3.22m USD
EBITDA TTM = 123.2m USD
Long Term Debt = 1.70b USD (from longTermDebt, last quarter)
Short Term Debt = 68.4m USD (from shortTermDebt, last quarter)
Debt = 1.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 495.8m USD (from netDebt column, last quarter)
Enterprise Value = 35.60b USD (37.09b + Debt 1.83b - CCE 3.32b)
Interest Coverage Ratio = 0.38 (Ebit TTM 3.22m / Interest Expense TTM 8.45m)
FCF Yield = 2.38% (FCF TTM 848.1m / Enterprise Value 35.60b)
FCF Margin = 29.93% (FCF TTM 848.1m / Revenue TTM 2.83b)
Net Margin = -1.45% (Net Income TTM -41.0m / Revenue TTM 2.83b)
Gross Margin = 76.66% ((Revenue TTM 2.83b - Cost of Revenue TTM 661.3m) / Revenue TTM)
Gross Margin QoQ = 76.56% (prev 76.05%)
Tobins Q-Ratio = 5.47 (Enterprise Value 35.60b / Total Assets 6.50b)
Interest Expense / Debt = 0.12% (Interest Expense 2.13m / Debt 1.83b)
Taxrate = -38.70% (negative due to tax credits) (3.24m / -8.37m)
NOPAT = 4.46m (EBIT 3.22m * (1 - -38.70%)) [negative tax rate / tax credits]
Current Ratio = 1.82 (Total Current Assets 4.21b / Total Current Liabilities 2.31b)
Debt / Equity = 0.93 (Debt 1.83b / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 4.02 (Net Debt 495.8m / EBITDA 123.2m)
Debt / FCF = 0.58 (Net Debt 495.8m / FCF TTM 848.1m)
Total Stockholder Equity = 1.80b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.63% (Net Income -41.0m / Total Assets 6.50b)
RoE = -2.28% (Net Income TTM -41.0m / Total Stockholder Equity 1.80b)
RoCE = 0.09% (EBIT 3.22m / Capital Employed (Equity 1.80b + L.T.Debt 1.70b))
RoIC = 0.14% (NOPAT 4.46m / Invested Capital 3.22b)
WACC = 10.12% (E(37.09b)/V(38.92b) * Re(10.61%) + D(1.83b)/V(38.92b) * Rd(0.12%) * (1-Tc(-0.39)))
Discount Rate = 10.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.65%
[DCF Debug] Terminal Value 73.56% ; FCFE base≈769.7m ; Y1≈949.5m ; Y5≈1.62b
Fair Price DCF = 112.9 (DCF Value 18.01b / Shares Outstanding 159.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 31.44 | EPS CAGR: -31.04% | SUE: 0.71 | # QB: 0
Revenue Correlation: 98.58 | Revenue CAGR: 35.03% | SUE: 2.60 | # QB: 10
EPS next Quarter (2026-01-31): EPS=0.90 | Chg30d=+0.004 | Revisions Net=+21 | Analysts=43
EPS current Year (2026-07-31): EPS=3.82 | Chg30d=+0.147 | Revisions Net=+39 | Growth EPS=+16.6% | Growth Revenue=+23.3%
EPS next Year (2027-07-31): EPS=4.48 | Chg30d=+0.052 | Revisions Net=+18 | Growth EPS=+17.3% | Growth Revenue=+19.8%
Additional Sources for ZS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle